Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016249
Filing Date
2025-06-09
Accepted
2025-06-09 16:20:18
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06092025_040606.html 4  
1 form4-06092025_040606.xml 4 10467
  Complete submission text file 0001415889-25-016249.txt   11917
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STRATA SKIN SCIENCES, INC. 5 WALNUT GROVE DRIVE SUITE 140 HORSHAM PA 19044
Business Address
Humphries William D. (Reporting) CIK: 0001674278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 251034376